Marine Natural Products and Drug Resistance in Latent Tuberculosis
Pyrazinamide (PZA) is the only drug for the elimination of latent <i>Mycobacterium tuberculosis</i> (MTB) isolates. However, due to the increased number of PZA-resistance, the chances of the success of global TB elimination seems to be more prolonged. Recently, marine natural products (M...
Main Authors: | Muhammad Tahir Khan, Aman Chandra Kaushik, Aamer Iqbal Bhatti, Yu-Juan Zhang, Shulin Zhang, Amie Jinghua Wei, Shaukat Iqbal Malik, Dong Qing Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/17/10/549 |
Similar Items
-
The Biological and Clinical Aspects of a Latent Tuberculosis Infection
by: Nelli F. Khabibullina, et al.
Published: (2022-03-01) -
Pediatric Drug-Resistant Tuberculosis: The Current and Future Prospects for Management and Prevention
by: Dhanya Dharmapalan, et al.
Published: (2023-11-01) -
The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide
by: Géraldine Daneau, et al.
Published: (2016-01-01) -
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
by: Giuseppe Mancuso, et al.
Published: (2023-09-01) -
Rapid Detection of Mycobacterium Tuberculosis Using a Novel Point-of-Care BZ TB/NTM NALF Assay: Integrating LAMP and LFIA Technologies
by: Ha Nui Kim, et al.
Published: (2023-04-01)